CAPS
Capstone Holding Corp.
NASDAQ · Basic Materials · Construction Materials · US
$0.18
−3.13%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
0.8x
EV/EBITDA
−3.3x
Market Cap
$3.76M
MomentumView details →
1D Return
−3.13%
YTD Return
−75.24%
RSI (14)
32.4
ValuationView details →
P/E (Fwd)
0.8x
EV/EBITDA
−3.3x
Market Cap
$3.76M
RSI (14)
32.4
MomentumView details →
1D Return
−3.13%
YTD Return
−75.24%
SummaryUpdated Jun 1, 2026
Capstone Therapeutics Corp. (NASDAQ:CAPS) is a biotechnology company founded in 1987 and headquartered in Tempe, Arizona. Originally established as OrthoLogic Corp., the company changed its name to Capstone Therapeutics Corp. in May 2010. The company went public in 1993 and has since focused on developing novel peptides and other molecules to address underserved medical conditions. Capstone operates in the competitive biotechnology sector, where companies develop innovative treatments and therapies through extensive research and clinical trials.
Similar companies
Latest newsMore news →
Capstone Holding Corp. filed a Form 8-K with the SEC containing its second quarter investor materials.24d agoCapstone Holding Corp. amended its Second Amended and Restated Stream Finance Credit Agreement, extending the maturity date to September 30, 2028, and deferring payment of previously accrued interest installments to that date, with outstanding principal of $2,581,088 as of March 31, 2026.76d agoCapstone Holding Corp. amended its secured revolving credit and term loan facility with Beacon Bank & Trust, extending the maturity date to December 31, 2026, with a revolving commitment of up to $11.5 million and an outstanding balance of about $9.56 million as of March 31, 2026.76d ago